An analogue of a kinase inhibitor exhibits subjective characteristics that contribute to its inhibitory activities as a potential anti-cancer candidate: insights through computational biomolecular modelling of UM-164 binding with lyn protein.

RSC Adv · 2019 · PMC9047091 · PMID 35492550

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

quite significantno p-value reported

The difference in the binding free energy between the lyn-Dasatinib and lyn-UM-164 is −5.175 ± 2.076 kcal mol −1 , which is quite significant.

also in 5,695 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.